Schuck R, Ward A, Sahoo A, Rybak J, Pyron R, Trybala T
Commun Biol. 2025; 8(1):411.
PMID: 40069393
PMC: 11897322.
DOI: 10.1038/s42003-025-07786-6.
Tanaka T, Kaneko Y, Yamamoto H, Li G, Fujisawa S, Satofuka H
Biochem Biophys Rep. 2025; 41:101960.
PMID: 40065768
PMC: 11891606.
DOI: 10.1016/j.bbrep.2025.101960.
Torres M, Gruer L, Valsaraj S, Reece S, Prokop J, Zeczycki T
Int J Mol Sci. 2025; 26(4).
PMID: 40003866
PMC: 11855005.
DOI: 10.3390/ijms26041398.
Yang X, Wang Y, Qiao Y, Lin J, Lau J, Fu W
Proc Natl Acad Sci U S A. 2025; 122(7):e2420324122.
PMID: 39928878
PMC: 11848297.
DOI: 10.1073/pnas.2420324122.
Lavareze L, Kimura T, Scarini J, de Lima-Souza R, Goncalves M, Sales de Sa R
Front Oncol. 2025; 14:1520306.
PMID: 39839790
PMC: 11746119.
DOI: 10.3389/fonc.2024.1520306.
Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions.
Farahani N, Alimohammadi M, Raei M, Nabavi N, Aref A, Hushmandi K
J Cell Commun Signal. 2024; 18(4):e12054.
PMID: 39691874
PMC: 11647052.
DOI: 10.1002/ccs3.12054.
Constrained β-Hairpins Targeting the EphA4 Ligand Binding Domain.
Prentiss A, Baggio C, Pagett J, Kulinich A, Ethell I, Muzzarelli K
J Med Chem. 2024; 67(24):22245-22253.
PMID: 39656022
PMC: 11684737.
DOI: 10.1021/acs.jmedchem.4c02286.
Reciprocal tumor-platelet interaction through the EPHB1-EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma.
Yao L, Qin W, Hu L, Shi T, Yu Yang J, Li Q
Cancer Commun (Lond). 2024; 45(2):143-166.
PMID: 39648610
PMC: 11833672.
DOI: 10.1002/cac2.12637.
Phosphatidylinositol 4,5-bisphosphate drives the formation of EGFR and EphA2 complexes.
Kumar Singh P, Rybak J, Schuck R, Sahoo A, Buck M, Barrera F
Sci Adv. 2024; 10(49):eadl0649.
PMID: 39630914
PMC: 11616708.
DOI: 10.1126/sciadv.adl0649.
EphB4 and ephrin-B1 expression in the intra-testicular-resident macrophages in mice.
Gofur M, Ogawa K
J Adv Vet Anim Res. 2024; 11(3):746-753.
PMID: 39605768
PMC: 11590604.
DOI: 10.5455/javar.2024.k826.
EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.
Toracchio L, Carrabotta M, Mancarella C, Morrione A, Scotlandi K
Int J Mol Sci. 2024; 25(22).
PMID: 39596256
PMC: 11594831.
DOI: 10.3390/ijms252212191.
Hepatic SerpinA1 improves energy and glucose metabolism through regulation of preadipocyte proliferation and UCP1 expression.
Okagawa S, Sakaguchi M, Okubo Y, Takekuma Y, Igata M, Kondo T
Nat Commun. 2024; 15(1):9585.
PMID: 39532838
PMC: 11557585.
DOI: 10.1038/s41467-024-53835-9.
Structures and pH-dependent dimerization of the sevenless receptor tyrosine kinase.
Cerutti G, Arias R, Bahna F, Mannepalli S, Katsamba P, Ahlsen G
Mol Cell. 2024; 84(23):4677-4690.e6.
PMID: 39510067
PMC: 11625006.
DOI: 10.1016/j.molcel.2024.10.017.
Master regulators of neurogenesis: the dynamic roles of Ephrin receptors across diverse cellular niches.
Rasool D, Jahani-Asl A
Transl Psychiatry. 2024; 14(1):462.
PMID: 39505843
PMC: 11541728.
DOI: 10.1038/s41398-024-03168-4.
Canonical ligand-dependent and non-canonical ligand-independent EphA2 signaling in the eye lens of wild-type, knockout, and aging mice.
Horner J, Vu M, Clark J, Innis I, Cheng C
Aging (Albany NY). 2024; 16(20):13039-13075.
PMID: 39466050
PMC: 11552635.
DOI: 10.18632/aging.206144.
EphA-Mediated Regulation of Stomatin Expression in Prostate Cancer Cells.
Nishida M, Sato A, Shimizu A, Rahman N, Wada A, Kageyama S
Cancer Med. 2024; 13(19):e70276.
PMID: 39377541
PMC: 11459579.
DOI: 10.1002/cam4.70276.
Imaging genetics of language network functional connectivity reveals links with language-related abilities, dyslexia and handedness.
Amelink J, Postema M, Kong X, Schijven D, Carrion-Castillo A, Soheili-Nezhad S
Commun Biol. 2024; 7(1):1209.
PMID: 39342056
PMC: 11438961.
DOI: 10.1038/s42003-024-06890-3.
EphB2 Signaling Is Implicated in Astrocyte-Mediated Parvalbumin Inhibitory Synapse Development.
Sutley-Koury S, Taitano-Johnson C, Kulinich A, Farooq N, Wagner V, Robles M
J Neurosci. 2024; 44(45).
PMID: 39327008
PMC: 11551896.
DOI: 10.1523/JNEUROSCI.0154-24.2024.
Targeting the EphA2 pathway: could it be the way for bone sarcomas?.
Giordano G, Tucciarello C, Merlini A, Cutrupi S, Pignochino Y
Cell Commun Signal. 2024; 22(1):433.
PMID: 39252029
PMC: 11382444.
DOI: 10.1186/s12964-024-01811-7.
Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide.
El Fakiri M, Regupathy A, Uhlmann L, Ayada N, Geis N, Domogalla L
Theranostics. 2024; 14(12):4701-4712.
PMID: 39239524
PMC: 11373624.
DOI: 10.7150/thno.96641.